Biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system disorders of System XC-
Location: United States, Wisconsin, Milwaukee
Total raised: $31M
Investors 5
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | F-Prime Ca... | fprimecapi... |
| - | OrbiMed | orbimed.co... |
| - | Golden Ang... | goldenange... |
| - | Eight Road... | eightroads... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.03.2017 | Series C | $26M | - |
| 22.01.2014 | Series B | $3M | - |
| 26.02.2010 | - | $2M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 31.03.2017 | Promentis Pharmaceuticals Inks $26M Series C | MILWAUKEE, WI, Privately-held biopharmaceutical company announced it has completed a third round o... | vcnewsdail... |
| 31.03.2017 | Term Sheet — Friday, March 31 | SCOOPS, PROFITS, IPOS, DEALS Cloudera is heavily funded. The company has raised more than $1 billio... | fortune.co... |
| 31.03.2017 | Telkonet, Wantable, Marquette, & More: This Week’s WI Wa... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints March into April by staying curren... | xconomy.co... |
| 30.03.2017 | Promentis Pharmaceuticals Closes $26M Series C Funding | Promentis Pharmaceuticals, Inc., a Milwaukee, Wisconsin-based biopharmaceutical company focused on t... | finsmes.co... |
| 30.03.2017 | Promentis Pharmaceuticals, Inc. Announces $26M Series C Fina... | Milwaukee, WI – March 30, 2017 – Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical... | aislingcap... |
| 12.10.2016 | Promentis, Kiio, EmOpti, & More: This Week’s Wisconsin W... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Take a break from raking leaves an... | xconomy.co... |
| 22.01.2014 | Promentis Pharmaceuticals Raises nearly $3M in Series B Fina... | Promentis Pharmaceuticals, Inc., a Milwaukee, WI-based specialty pharmaceutical company developing n... | finsmes.co... |
| 26.02.2010 | Promentis raises nearly $2M for schizophrenia drug developme... | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis... | medcitynew... |
| - | Promentis raises nearly $2M for schizophrenia drug developme... | Early stage drug developer Promentis Pharmaceuticals has raised $1.94 million in equity to continue ... | medcitynew... |